nodes	percent_of_prediction	percent_of_DWPC	metapath
Protriptyline—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Protriptyline—Stomatitis—Fludarabine—lymphatic system cancer	0.00608	0.00608	CcSEcCtD
Protriptyline—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Protriptyline—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00601	0.00601	CcSEcCtD
Protriptyline—Flushing—Teniposide—lymphatic system cancer	0.00591	0.00591	CcSEcCtD
Protriptyline—Anorexia—Mechlorethamine—lymphatic system cancer	0.00585	0.00585	CcSEcCtD
Protriptyline—Arrhythmia—Teniposide—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Protriptyline—Alopecia—Teniposide—lymphatic system cancer	0.00563	0.00563	CcSEcCtD
Protriptyline—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Protriptyline—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Protriptyline—Agitation—Teniposide—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Protriptyline—Arrhythmia—Fludarabine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Protriptyline—Leukopenia—Teniposide—lymphatic system cancer	0.00496	0.00496	CcSEcCtD
Protriptyline—Alopecia—Fludarabine—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Protriptyline—Bone marrow depression—Methotrexate—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Protriptyline—Pancytopenia—Bleomycin—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Protriptyline—Ataxia—Carmustine—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Protriptyline—Hypertension—Teniposide—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Protriptyline—Urinary retention—Vincristine—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Protriptyline—Ataxia—Vincristine—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Protriptyline—Confusional state—Teniposide—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Protriptyline—Oedema—Teniposide—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Protriptyline—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Protriptyline—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Protriptyline—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Protriptyline—Agitation—Fludarabine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Protriptyline—Stomatitis—Bleomycin—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Protriptyline—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Protriptyline—Tachycardia—Teniposide—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Protriptyline—Malaise—Fludarabine—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Protriptyline—Leukopenia—Fludarabine—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Protriptyline—Pruritus—Mechlorethamine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Protriptyline—Anorexia—Teniposide—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Protriptyline—Pancytopenia—Carmustine—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Protriptyline—Hypotension—Teniposide—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Protriptyline—Convulsion—Fludarabine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Protriptyline—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Protriptyline—Discomfort—Fludarabine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Protriptyline—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Protriptyline—Pancytopenia—Vincristine—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Protriptyline—Petechiae—Methotrexate—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Protriptyline—Confusional state—Fludarabine—lymphatic system cancer	0.00401	0.00401	CcSEcCtD
Protriptyline—Oedema—Fludarabine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Protriptyline—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Protriptyline—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Protriptyline—Decreased appetite—Teniposide—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Protriptyline—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Protriptyline—Vomiting—Mechlorethamine—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Protriptyline—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Protriptyline—Stomatitis—Carmustine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Protriptyline—Rash—Mechlorethamine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Protriptyline—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Protriptyline—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Protriptyline—Flushing—Bleomycin—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Protriptyline—Anorexia—Fludarabine—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Protriptyline—Weight increased—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Protriptyline—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Protriptyline—Myocardial infarction—Vincristine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Protriptyline—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Protriptyline—Feeling abnormal—Teniposide—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Protriptyline—Stomatitis—Vincristine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Protriptyline—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Protriptyline—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Protriptyline—Nausea—Mechlorethamine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Protriptyline—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Protriptyline—Alopecia—Bleomycin—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Protriptyline—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Protriptyline—Jaundice—Mitoxantrone—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Protriptyline—Urticaria—Teniposide—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Protriptyline—Abdominal pain—Teniposide—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Protriptyline—Body temperature increased—Teniposide—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Protriptyline—Paraesthesia—Fludarabine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Protriptyline—Hallucination—Carmustine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Protriptyline—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Protriptyline—Dyspepsia—Fludarabine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Protriptyline—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Protriptyline—Decreased appetite—Fludarabine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Protriptyline—Fatigue—Fludarabine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Protriptyline—Hypoaesthesia—Vincristine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Protriptyline—Hallucination—Vincristine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Protriptyline—Constipation—Fludarabine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Protriptyline—Flushing—Carmustine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Protriptyline—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Protriptyline—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Protriptyline—Asthenia—Teniposide—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Protriptyline—Malaise—Bleomycin—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Protriptyline—Pruritus—Teniposide—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Protriptyline—Arrhythmia—Carmustine—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Protriptyline—Leukopenia—Bleomycin—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Protriptyline—Alopecia—Carmustine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Protriptyline—Body temperature increased—Fludarabine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Protriptyline—Diarrhoea—Teniposide—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Protriptyline—Alopecia—Vincristine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Protriptyline—Discomfort—Bleomycin—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Protriptyline—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Protriptyline—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Protriptyline—Alopecia—Mitoxantrone—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Protriptyline—Confusional state—Bleomycin—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Protriptyline—Vision blurred—Carmustine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Protriptyline—Tremor—Carmustine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Protriptyline—Oedema—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Protriptyline—Vomiting—Teniposide—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Protriptyline—Agitation—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Protriptyline—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Protriptyline—Asthenia—Fludarabine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Protriptyline—Rash—Teniposide—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Protriptyline—Dermatitis—Teniposide—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Protriptyline—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Protriptyline—Headache—Teniposide—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Protriptyline—Pruritus—Fludarabine—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Protriptyline—Leukopenia—Carmustine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Protriptyline—Anorexia—Bleomycin—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Protriptyline—Agitation—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Protriptyline—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Protriptyline—Hypotension—Bleomycin—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Protriptyline—Diarrhoea—Fludarabine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Protriptyline—Convulsion—Carmustine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Protriptyline—Hypertension—Carmustine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Protriptyline—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Protriptyline—Nausea—Teniposide—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Protriptyline—Leukopenia—Vincristine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Protriptyline—Anxiety—Carmustine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Protriptyline—Paraesthesia—Bleomycin—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Protriptyline—Malaise—Mitoxantrone—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Protriptyline—Leukopenia—Mitoxantrone—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Protriptyline—Convulsion—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Protriptyline—Hypertension—Vincristine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Protriptyline—Confusional state—Carmustine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Protriptyline—Oedema—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Protriptyline—Decreased appetite—Bleomycin—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Protriptyline—Vomiting—Fludarabine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Protriptyline—Convulsion—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Protriptyline—Rash—Fludarabine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Protriptyline—Dermatitis—Fludarabine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Protriptyline—Hypertension—Mitoxantrone—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Protriptyline—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Protriptyline—Headache—Fludarabine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Protriptyline—Tachycardia—Carmustine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Protriptyline—Anxiety—Mitoxantrone—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Protriptyline—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Protriptyline—Discomfort—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Protriptyline—Oedema—Vincristine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Protriptyline—Anorexia—Carmustine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Protriptyline—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Protriptyline—Confusional state—Mitoxantrone—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Protriptyline—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Protriptyline—Hypotension—Carmustine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Protriptyline—Oedema—Mitoxantrone—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Protriptyline—Nausea—Fludarabine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Protriptyline—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Protriptyline—Urticaria—Bleomycin—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Protriptyline—Anorexia—Vincristine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Protriptyline—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Protriptyline—Body temperature increased—Bleomycin—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Protriptyline—Insomnia—Carmustine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Protriptyline—Paraesthesia—Carmustine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Protriptyline—Hypotension—Vincristine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Protriptyline—Somnolence—Carmustine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Protriptyline—Anorexia—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Protriptyline—Ataxia—Methotrexate—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Protriptyline—Decreased appetite—Carmustine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Protriptyline—Hypotension—Mitoxantrone—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Protriptyline—Insomnia—Vincristine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Protriptyline—Paraesthesia—Vincristine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Protriptyline—Constipation—Carmustine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Protriptyline—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Protriptyline—Decreased appetite—Vincristine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Protriptyline—Somnolence—Mitoxantrone—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Protriptyline—Feeling abnormal—Carmustine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Protriptyline—Fatigue—Vincristine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Protriptyline—Asthenia—Bleomycin—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Protriptyline—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Protriptyline—Constipation—Vincristine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Protriptyline—Pruritus—Bleomycin—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Protriptyline—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Protriptyline—Eosinophilia—Methotrexate—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Protriptyline—Fatigue—Mitoxantrone—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Protriptyline—Constipation—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Protriptyline—Abdominal pain—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Protriptyline—Body temperature increased—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Protriptyline—Pancytopenia—Methotrexate—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Protriptyline—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Protriptyline—Abdominal pain—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Protriptyline—Body temperature increased—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Protriptyline—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Protriptyline—Urticaria—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Protriptyline—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Protriptyline—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Protriptyline—Vomiting—Bleomycin—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Protriptyline—Drowsiness—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Protriptyline—Rash—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Protriptyline—Dermatitis—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Protriptyline—Asthenia—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Protriptyline—Stomatitis—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Protriptyline—Asthenia—Vincristine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Protriptyline—Diarrhoea—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Protriptyline—Nausea—Bleomycin—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Protriptyline—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Protriptyline—Asthenia—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Protriptyline—Dizziness—Carmustine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Protriptyline—Diarrhoea—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Protriptyline—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Protriptyline—Vomiting—Carmustine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Protriptyline—Dizziness—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Protriptyline—Rash—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Protriptyline—Dermatitis—Carmustine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Protriptyline—Headache—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Protriptyline—Tinnitus—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Protriptyline—Vomiting—Vincristine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Protriptyline—Rash—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Protriptyline—Dermatitis—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Protriptyline—Headache—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Protriptyline—Nausea—Carmustine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Protriptyline—Vomiting—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Protriptyline—Rash—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Protriptyline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Protriptyline—Headache—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Protriptyline—Alopecia—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Protriptyline—Nausea—Vincristine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Protriptyline—Dysgeusia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Protriptyline—Nausea—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Protriptyline—Vision blurred—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Protriptyline—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Protriptyline—Malaise—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Protriptyline—Leukopenia—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Protriptyline—Convulsion—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Protriptyline—Discomfort—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Protriptyline—Confusional state—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Protriptyline—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Protriptyline—Anorexia—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Protriptyline—Hypotension—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Protriptyline—Insomnia—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Protriptyline—Paraesthesia—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Protriptyline—Somnolence—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Protriptyline—Dyspepsia—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Protriptyline—Decreased appetite—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Protriptyline—Fatigue—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Protriptyline—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Protriptyline—Urticaria—Methotrexate—lymphatic system cancer	0.000937	0.000937	CcSEcCtD
Protriptyline—Body temperature increased—Methotrexate—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Protriptyline—Abdominal pain—Methotrexate—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Protriptyline—Asthenia—Methotrexate—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Protriptyline—Pruritus—Methotrexate—lymphatic system cancer	0.000834	0.000834	CcSEcCtD
Protriptyline—Diarrhoea—Methotrexate—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Protriptyline—Dizziness—Methotrexate—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Protriptyline—Vomiting—Methotrexate—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Protriptyline—Rash—Methotrexate—lymphatic system cancer	0.000744	0.000744	CcSEcCtD
Protriptyline—Dermatitis—Methotrexate—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Protriptyline—Headache—Methotrexate—lymphatic system cancer	0.000739	0.000739	CcSEcCtD
Protriptyline—Nausea—Methotrexate—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
